Denis Wakefield

Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial

R. Lenroot, T. Weickert, Dennis Liu, 2023, Brain, Behavior, and Immunity.

Balance of Pro- and Anti-Inflammatory Cytokines Correlates with Outcome of Acute Experimental Pseudomonas aeruginosa Keratitis

D. Wakefield, F. Stapleton, A. Lloyd, 2002, Infection and Immunity.